AUG 1, 2026 · JOURNAL ARTICLE
Baseline cardiovascular risk assessment in patients receiving proteasome inhibitors for haematological malignancies: a tertiary referral centre experience
European Heart Journal Supplements
Single-centre retrospective audit of compliance with published ESC surveillance guidance; identifies practice gaps rather than testing an intervention, with no comparator group or efficacy endpoint.
Reported
Sample size216
Proportion male50%
Proportion with multiple myeloma88.9%